Pressure BioSciences, Inc.
PBIO · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,116 | -$8,074 | -$9,904 | -$5,630 |
| Dep. & Amort. | $90 | $76 | $28 | $28 |
| Deferred Tax | $0 | $0 | $35 | $6 |
| Stock-Based Comp. | $83 | $319 | $2,380 | $141 |
| Change in WC | $1,704 | $693 | $1,870 | $731 |
| Other Non-Cash | $4,535 | $5,127 | $4,459 | $3,992 |
| Operating Cash Flow | -$706 | -$1,860 | -$1,132 | -$732 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$7,488 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$7,488 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $717 | $1,782 | $840 | $717 |
| Stock Issued | $923,245 | $1,136,790 | $8,226,036 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1,264,106 | -$38,838 | $0 | $0 |
| Other Fin. Act. | $1,264,106 | $0 | $368 | $0 |
| Financing Cash Flow | $717 | $1,782 | $1,208 | $717 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $11 | -$78 | $76 | -$20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3 | $81 | $5 | $25 |
| End Cash | $14,253 | $3 | $81 | $5 |
| Free Cash Flow | -$706 | -$1,860 | -$8,620 | -$737 |